Morgan Stanley Has Lowered Expectations for Kyverna Therapeutics (NASDAQ:KYTX) Stock Price
Kyverna Therapeutics (NASDAQ:KYTX – Get Free Report) had its price target cut by investment analysts at Morgan Stanley from $40.00 to $20.00 in a research note issued on Tuesday,Benzinga reports. The firm currently has an “overweight” rating on the stock. Kyverna Therapeutics Trading Up 8.6 % Shares of KYTX stock opened at $2.15 on Tuesday. […]
Kyverna Therapeutics (NASDAQ:KYTX – Get Free Report) had its price target cut by investment analysts at Morgan Stanley from $40.00 to $20.00 in a research note issued on Tuesday,Benzinga reports. The firm currently has an “overweight” rating on the stock. Kyverna Therapeutics Trading Up 8.6 % Shares of KYTX stock opened at $2.15 on Tuesday. […]
